REIG JOFRÉ. new agreement with REIG-JOFRÉ.

The pharmaceutical sector keeps being one of reference sectors for ENFLEX and in which it is increasing its presence. The company Reig Jofré Group from Sant Joan Despí, has chosen one of ENFLEX’s machines, concretely the model F-11 Duplex.

F-11 DX filler for wipes; effective sealing.

The model that Grupo Reig-Jofré has purchased is an automatic packaging machine designed for the processes of forming, filling and sealing of pouches for wipes or swabs. This is a sector that has experienced a remarkable growth in the past years and to which ENFLEX offers efficient solutions in regards to production, maintenance and costs.

The working process of the F-11 DX filler begins with the forming of the wipe, which comes from a reel where the material is gathered before being folded, cut and introduced into the pouch together with the dose of liquid and/or cream to impregnate it with.

The working cycle finishes with the closing and sealing of the pouch and its cutting to leave it displayed in units.
 

Reig –Jofré Group, constant growth   

The headquarters of Reig Jofré Group is located in Sant Joan Despí, where it was moved eleven years ago in what was the great expansion process that began as a family business created in 1929, engaged then in the production of compounding. That business kept growing and becoming strong in the pharmaceutical sector until it reached the creation of a limited company in the 70s.

Currently, at the headquarters of Sant Joan Despí, 250 employees work and the various processes carried out are concentrated in three divisions:

•Industrial services: focused on generic products, manufacturing for third parties with the speciality of llyophilized and sterilized products.

•Pharma Division: it is engaged into the commercialization of medicine and products under license by the brands Reig Jofré, Medea, Orravan and Sala.

•I+D and regulatory services division: its field is the identification of relevant development projects for the national and international markets.

Recently, the company has carried out an investment of 10 million Euros in the building of a new area of processes of lyophilization and liquids. It also has a second headquarters in Toledo which is specialized in the production of oral sterile penicillanic products and sterile cephalosporin products. Furthermore, the purchase of the Swedish laboratories BIOGLAN, specialized in skin care and liquid products has to be added, as well as the collaboration with ORYZON, a company specialized in biotechnology.

In the future, Reig Jofré Group will expand its activities to the production of syrups, and a technological renewal is also among its projects.